Stocks and Investing Stocks and Investing
Tue, July 8, 2014
Mon, July 7, 2014
Wed, July 2, 2014
Tue, July 1, 2014
Mon, June 30, 2014
Fri, June 27, 2014
Thu, June 26, 2014
Wed, June 25, 2014
Tue, June 24, 2014
Mon, June 23, 2014
Fri, June 20, 2014
Thu, June 19, 2014
Wed, June 18, 2014
Tue, June 17, 2014
Mon, June 16, 2014
Fri, June 13, 2014
Thu, June 12, 2014
Wed, June 11, 2014
Tue, June 10, 2014
Mon, June 9, 2014
Fri, June 6, 2014
Thu, June 5, 2014
Wed, June 4, 2014
Tue, June 3, 2014
Mon, June 2, 2014
Fri, May 30, 2014
Thu, May 29, 2014

Cory Kasimov Upgraded (BIIB) to Buy and Increased Target to $375 on, May 29th, 2014


Published on 2024-10-25 05:07:03 - WOPRAI, Cory Kasimov
  Print publication without navigation


Cory Kasimov of JP Morgan, Upgraded "Biogen Inc." (BIIB) to Buy and Increased Target from $300 to $375 on, May 29th, 2014.

Cory has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Cory's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Cory


  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $415 on, Thursday, April 24th, 2014
  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $395 on, Thursday, March 27th, 2014
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $400 on, Friday, February 14th, 2014
Similar Stocks and Investing Articles